AGNUSFEMINA 4 mg film-coated tablets menstrual irregularities, mastodynia
Active ingredient: dry extract of chaste fruit for
menstrual irregularities (regular pace anomalies), feeling of tension and swelling in the breasts (mastodynia), monthly recurring complaints before the menstrual period starts (premenstrual complaints).
Warning: contains lactose.
Agnusfemina® 4 mg film-coated tablets
Containing the high-quality dry extract of chasteberry fruits, it is rich in prolactin-lowering substances and addresses the root cause of PMS—hormonal imbalance. It relieves both physical and psychological symptoms of PMS.
How to take:
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Consult your doctor or pharmacist if you are not sure.
The recommended dose is one film-coated tablet (equivalent to 40 mg of the drug) once daily.
Agnusfemina should be taken at the same time of day every day, if possible.
For reliable results, Agnusfemina should be taken for at least three monthly cycles.
What Agnusfemina contains:
The active ingredient is dry extract of fenugreek fruits (7–13:1). One film-coated tablet contains 4 mg dry extract of fenugreek fruits (7–13:1), extraction agent: ethanol 60% (w/w).
The other ingredients are: lactose monohydrate (see section 2), microcrystalline cellulose, glucose syrup (dry substance; see section 2), maize starch, sodium carboxymethyl starch (type A), hypromellose, titanium dioxide E 171, highly dispersed silicon dioxide, magnesium stearate, macrogol 4000, iron (III) oxide E 172.
Note for diabetics: One film-coated tablet contains 0.015 bread units (BU).
Mandatory text:
Active ingredient: Dried fenugreek fruit extract. Indications: For menstrual rhythm disorders (period irregularities), breast tension and swelling (mastodynia), and monthly recurring symptoms before the onset of menstruation (premenstrual symptoms). Warning: Contains lactose and glucose.
For risks and side effects, read the package leaflet and ask your doctor or pharmacist
As of: October 2024. mibe GmbH Arzneimittel, 06796 Brehna.